GNDU scientist obtains patent for antifungal drug formulation : The Tribune India


Tribune press service

Amritsar, June 3

Dr. Subheet K Jain, Professor in the Department of Pharmaceutical Sciences and Coordinator of the Center for Basic and Translational Research in Health Sciences, Guru Nanak Dev University, was granted a patent titled “Non-Settling Nanovesicular Formulation for the Delivery of amphotericin B” for a period of 20 years Government of India.

Sharing the news, Dr. Jain informed that in this patent, a new antifungal drug formulation has been developed. “The developed formulation is very effective for the treatment of systemic fungal diseases. It is safe in nature and due to its low melting it is within reach of common people,” he said. Dr. Jain also informed that due to environmental changes, cases of fungal diseases are on the increase. This formulation will help provide low cost therapy to ordinary people.

VC Prof Jaspal Singh Sandhu, Senior Researchers and Faculty Members, Researchers and Co-Authors from Department of Pharmaceutical Sciences, GNDU applauded Dr. Jain’s efforts for his outstanding research work.

Dr. Subhneet Jain was previously included in the list of the top 2% of the world’s scientists for the year 2021, published by Stanford University, USA, in PloS Biology. Dr. Jain’s laboratory has published over 130 research papers in internationally renowned journals. He has also written 12 book chapters and has already obtained two patents. He has successfully completed 10 research projects funded by various agencies such as DST, AICTE, ICMR and UGC, New Delhi. Currently, six researchers (including two international students) are working in his laboratory on different research projects related to the development of safe and cost-effective formulations for antifungal and anticancer drugs.


Comments are closed.